EUVIMEDEUVIMED entdecken
Systematische ÜbersichtMetaanalyse

Efficacy of lactoferrin supplementation in pediatric infections: a systematic review and meta-analysis

Valerie S Mayorga, Rafaella Navarro, Victor D Torres Roldan, Meritxell Urtecho, Silvia Tipe, Bea Calvert, Laura A Wright, Theresa J Ochoa iD

Biochemistry and Cell Biology · 2025

DOI: 10.1139/bcb-2024-0181 ↗

Kurz gefasst

Systematische Übersicht in der Zeitschrift Biochemistry and Cell Biology, 2025. Verfasst von Valerie S Mayorga und 7 weiteren Autor:innen. Beteiligte Einrichtung: Instituto de Medicina Tropical Alexander von Humboldt, Universidad Peruana Cayetano Heredia, Lima, Peru. Hauptthemen laut MEDLINE: Lactoferrin, Dietary Supplements, Diarrhea, Respiratory Tract Infections. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 43 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Pediatric infections account for approximately one-third of all deaths in children under 5 years globally. Lactoferrin (LF) supplementation has the potential to reduce infection-related morbidity due to its antimicrobial, anti-inflammatory, and immunoregulatory properties. We conducted a systematic review and meta-analysis of oral LF supplementation randomized controlled trials in population under 18 years old. The primary outcomes were infection-associated outcomes: late onset sepsis (LOS), diarrhea, and upper respiratory infections (URIs). We also analyzed mortality among LOS studies. Of 1594 citations identified, 25 studies met eligibility criteria, including 10 studies of LOS, 14 of diarrhea, and 8 of URI. LF supplementation was associated with fewer patients with culture-proven or probable neonatal LOS compared to placebo (odds ratio (OR): 0.60; 95% confidence interval (CI): 0.42–0.86), with fewer patients with diarrhea compared to placebo in children (OR: 0.56; 95% CI: 0.41–0.75), and no significant fewer patients with URI (OR: 0.61; 95% CI: 0.27–1.40). Before LF can be used as a public health intervention, it is necessary to refine some aspects of the design of future trials. Ideally these trials should be conducted in countries with the highest burden of infections, where the potential benefit is expected to have the largest impact.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

LactoferrinDietary SupplementsDiarrheaRespiratory Tract InfectionsSepsisHumansChildRandomized Controlled Trials as TopicChild, Preschool

Stichwörter der Autor:innen

adolescentchildrendiarrhealactoferrinrespiratory infectionssepsis

Substanzen

Lactoferrin

Autor:innen und Institutionen

  • Instituto de Medicina Tropical Alexander von Humboldt, Universidad Peruana Cayetano Heredia, Lima, Peru.
  • Department of Pediatrics, Tulane School of Medicine, Tulane University, New Orleans, LA, USA.
  • Department of Internal Medicine, Tulane School of Medicine, Tulane University, New Orleans, LA, USA.
  • Facultad de Medicina, Universidad Peruana Cayetano Heredia, Lima, Peru.
  • Tulane University, New Orleans, LA, USA.

ORCID-Profile: Theresa J Ochoa

Zitieren

APA

Mayorga, V., Navarro, R., Roldan, V., Urtecho, M., Tipe, S., Calvert, B., Wright, L., & Ochoa, T. J. (2025). Efficacy of lactoferrin supplementation in pediatric infections: a systematic review and meta-analysis. Biochemistry and Cell Biology. https://doi.org/10.1139/bcb-2024-0181

Vancouver

Mayorga V, Navarro R, Roldan V, Urtecho M, Tipe S, Calvert B, et al. Efficacy of lactoferrin supplementation in pediatric infections: a systematic review and meta-analysis. Biochemistry and Cell Biology. 2025. doi:10.1139/bcb-2024-0181

BibTeX
@article{Mayorga2025,
  author = {Mayorga, Valerie S and Navarro, Rafaella and Roldan, Victor D Torres and Urtecho, Meritxell and Tipe, Silvia and Calvert, Bea and Wright, Laura A and Ochoa, Theresa J},
  title = {Efficacy of lactoferrin supplementation in pediatric infections: a systematic review and meta-analysis},
  journal = {Biochemistry and Cell Biology},
  year = {2025},
  doi = {10.1139/bcb-2024-0181}
}
Kostenlos starten →